Editas Medicine Other Long Term Liabilities (Quarterly) Trends

Editas Medicine, Inc. (EDIT)

2.23 +0.14 (+6.70%) USD | NASDAQ | Jan 14, 12:16

View Other Long Term Liabilities (Quarterly) for EDIT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

ADMA Biologics, Inc.	Upgrade
Arcutis Biotherapeutics, Inc.	Upgrade
Daré Bioscience, Inc.	Upgrade
Cogent Biosciences, Inc.	Upgrade
Janux Therapeutics, Inc.	--